• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AV-TEMECULA-CT ABSORB BIORESORBABLE VASCULAR SCAFFOLD SYSTEM; BIORESORBABLE DRUG ELUTING SCAFFOLD

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AV-TEMECULA-CT ABSORB BIORESORBABLE VASCULAR SCAFFOLD SYSTEM; BIORESORBABLE DRUG ELUTING SCAFFOLD Back to Search Results
Catalog Number 1012464-18
Device Problem Difficult or Delayed Positioning (1157)
Patient Problems Aneurysm (1708); Angina (1710); Cardiac Enzyme Elevation (1838); Myocardial Infarction (1969); Stenosis (2263); Diaphoresis (2452)
Event Date 07/26/2016
Event Type  Injury  
Manufacturer Narrative
(b)(4).During processing of this complaint, attempts were made to obtain complete event, patient and device information.The device was not returned for evaluation.A review of the lot history record revealed no manufacturing nonconformities that would have contributed to this complaint.Additionally, a review of the complaint history identified no other similar incidents from this lot.The reported patient effects of angina, aneurysm, myocardial infarction and restenosis, as listed in the bioresorbable vascular scaffold (bvs) system, absorb, instructions for use are known adverse events associated with the use of a coronary scaffold in native coronary arteries.Based on the information reviewed, a conclusive cause for the reported difficulty to deploy and patient effects could not be determined and there is no indication of a product quality issue with respect to the design, manufacture or labeling of the device.Attachment: article - coronary aneurysm formation after bioresorbable vascular scaffold implantation resulting in acute myocardial infarction.
 
Event Description
The following information was reported from an article titled "coronary aneurysm formation after bioresorbable vascular scaffold implantation resulting in acute myocardial infarction." the elective procedure was to treat an 80% stenosis in the proximal left anterior descending (lad) artery.The patient had been experiencing chest pain and a treadmill test was positive for ischemia.After lesion pre-dilatation, a 3.5 x 18 mm absorb scaffold was implanted.Post dilatation was performed.Final angiographic image showed excellent flow.Intravascular ultrasound (ivus) showed optimal scaffold wall apposition at the proximal area, but suboptimal result over the distal area.Due to the good angiographic result and for fear of deforming the scaffold, no additional post-dilatation was performed.The patient was discharged the following day with dual antiplatelet therapy (dapt).On (b)(6) 2016, the patient began experiencing severe chest pain and profuse diaphoresis.Nitroglycerin was taken, but the pain persisted and the patient was taken to the emergency room.Electrocardiogram was normal, but ck-mb levels were elevated.A non st elevation myocardial infarction was suspected so the patient was given loading doses of dapt and heparin.Angiography and ivus noted a non-significant distal edge restenosis and a small aneurysm immediately after the first diagonal (d1) branch.Pre-dilatation was performed and a stent was implanted followed by post-dilatation, resolving the symptoms.2 days later, the patient was discharged.No additional information was provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ABSORB BIORESORBABLE VASCULAR SCAFFOLD SYSTEM
Type of Device
BIORESORBABLE DRUG ELUTING SCAFFOLD
Manufacturer (Section D)
AV-TEMECULA-CT
abbott vascular
26531 ynez road
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, TEMECULA, CA USA REG# 2024168
abbott vascular
26531 ynez road
temecula CA 92591 4628
Manufacturer Contact
connie speck
abbott vascular
26531 ynez road
temecula, CA 92591-4628
9519143996
MDR Report Key6608775
MDR Text Key76550024
Report Number2024168-2017-04730
Device Sequence Number1
Product Code PNY
UDI-Device Identifier08717648157103
UDI-Public(01)08717648157103(17)161206(10)5120862
Combination Product (y/n)N
Reporter Country CodeTW
PMA/PMN Number
P150023
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type literature
Reporter Occupation Health Professional
Remedial Action Other
Type of Report Initial
Report Date 06/02/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date12/06/2016
Device Catalogue Number1012464-18
Device Lot Number5120862
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 05/25/2017
Initial Date FDA Received06/02/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured12/01/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention; Disability;
Patient Age62 YR
-
-